Childhood  ||| S:0 E:10 ||| JJ
maltreatment  ||| S:10 E:23 ||| NN
and  ||| S:23 E:27 ||| CC
adult  ||| S:27 E:33 ||| NN
psychopathology ||| S:33 E:48 ||| NNS
:  ||| S:48 E:50 ||| :
pathways  ||| S:50 E:59 ||| VBG
to  ||| S:59 E:62 ||| TO
hypothalamic-pituitary-adrenal  ||| S:62 E:93 ||| JJ
axis  ||| S:93 E:98 ||| NNS
dysfunction  ||| S:98 E:110 ||| VBP
The  ||| S:110 E:114 ||| DT
aim  ||| S:114 E:118 ||| NN
of  ||| S:118 E:121 ||| IN
this  ||| S:121 E:126 ||| DT
paper  ||| S:126 E:132 ||| NN
was  ||| S:132 E:136 ||| VBD
to  ||| S:136 E:139 ||| TO
examine  ||| S:139 E:147 ||| VB
the  ||| S:147 E:151 ||| DT
relationship  ||| S:151 E:164 ||| NN
between  ||| S:164 E:172 ||| IN
childhood  ||| S:172 E:182 ||| NN
maltreatment  ||| S:182 E:195 ||| NNS
and  ||| S:195 E:199 ||| CC
adult  ||| S:199 E:205 ||| NN
psychopathology ||| S:205 E:220 ||| NN
,  ||| S:220 E:222 ||| ,
as  ||| S:222 E:225 ||| RB
reflected  ||| S:225 E:235 ||| VBN
in  ||| S:235 E:238 ||| IN
hypothalamic-pituitary-adrenal  ||| S:238 E:269 ||| JJ
axis  ||| S:269 E:274 ||| JJ
dysfunction ||| S:274 E:285 ||| NN
.  ||| S:285 E:287 ||| .
A  ||| S:287 E:289 ||| DT
selective  ||| S:289 E:299 ||| JJ
review  ||| S:299 E:306 ||| NN
of  ||| S:306 E:309 ||| IN
the  ||| S:309 E:313 ||| DT
relevant  ||| S:313 E:322 ||| JJ
literature  ||| S:322 E:333 ||| NN
was  ||| S:333 E:337 ||| VBD
undertaken  ||| S:337 E:348 ||| VBN
in  ||| S:348 E:351 ||| IN
order  ||| S:351 E:357 ||| NN
to  ||| S:357 E:360 ||| TO
identify  ||| S:360 E:369 ||| VB
key  ||| S:369 E:373 ||| JJ
and  ||| S:373 E:377 ||| CC
illustrative  ||| S:377 E:390 ||| JJ
research  ||| S:390 E:399 ||| NN
findings ||| S:399 E:407 ||| NNS
.  ||| S:407 E:409 ||| .
There  ||| S:409 E:415 ||| EX
is  ||| S:415 E:418 ||| VBZ
now  ||| S:418 E:422 ||| RB
a  ||| S:422 E:424 ||| DT
substantial  ||| S:424 E:436 ||| JJ
body  ||| S:436 E:441 ||| NN
of  ||| S:441 E:444 ||| IN
preclinical  ||| S:444 E:456 ||| NN
and  ||| S:456 E:460 ||| CC
clinical  ||| S:460 E:469 ||| JJ
evidence  ||| S:469 E:478 ||| NN
derived  ||| S:478 E:486 ||| VBN
from  ||| S:486 E:491 ||| IN
a  ||| S:491 E:493 ||| DT
variety  ||| S:493 E:501 ||| NN
of  ||| S:501 E:504 ||| IN
experimental  ||| S:504 E:517 ||| JJ
paradigms  ||| S:517 E:527 ||| NNS
showing  ||| S:527 E:535 ||| VBG
how  ||| S:535 E:539 ||| WRB
early-life  ||| S:539 E:550 ||| JJ
stress  ||| S:550 E:557 ||| NN
is  ||| S:557 E:560 ||| VBZ
related  ||| S:560 E:568 ||| VBN
to  ||| S:568 E:571 ||| TO
hypothalamic-pituitary-adrenal  ||| S:571 E:602 ||| JJ
axis  ||| S:602 E:607 ||| JJ
function  ||| S:607 E:616 ||| NN
and  ||| S:616 E:620 ||| CC
psychological  ||| S:620 E:634 ||| JJ
state  ||| S:634 E:640 ||| NN
in  ||| S:640 E:643 ||| IN
adulthood ||| S:643 E:652 ||| NN
,  ||| S:652 E:654 ||| ,
and  ||| S:654 E:658 ||| CC
how  ||| S:658 E:662 ||| WRB
that  ||| S:662 E:667 ||| DT
relationship  ||| S:667 E:680 ||| NN
can  ||| S:680 E:684 ||| MD
be  ||| S:684 E:687 ||| VB
modulated  ||| S:687 E:697 ||| VBN
by  ||| S:697 E:700 ||| IN
other  ||| S:700 E:706 ||| JJ
factors ||| S:706 E:713 ||| NNS
.  ||| S:713 E:715 ||| .
The  ||| S:715 E:719 ||| DT
risk  ||| S:719 E:724 ||| NN
for  ||| S:724 E:728 ||| IN
adult  ||| S:728 E:734 ||| NN
psychopathology  ||| S:734 E:750 ||| NNS
and  ||| S:750 E:754 ||| CC
hypothalamic-pituitary-adrenal  ||| S:754 E:785 ||| JJ
axis  ||| S:785 E:790 ||| JJ
dysfunction  ||| S:790 E:802 ||| NN
is  ||| S:802 E:805 ||| VBZ
related  ||| S:805 E:813 ||| VBN
to  ||| S:813 E:816 ||| TO
a  ||| S:816 E:818 ||| DT
complex  ||| S:818 E:826 ||| JJ
interaction  ||| S:826 E:838 ||| NN
among  ||| S:838 E:844 ||| IN
multiple  ||| S:844 E:853 ||| JJ
experiential  ||| S:853 E:866 ||| JJ
factors ||| S:866 E:873 ||| NNS
,  ||| S:873 E:875 ||| ,
as  ||| S:875 E:878 ||| RB
well  ||| S:878 E:883 ||| RB
as  ||| S:883 E:886 ||| RB
to  ||| S:886 E:889 ||| TO
susceptibility  ||| S:889 E:904 ||| VB
genes  ||| S:904 E:910 ||| NNS
that  ||| S:910 E:915 ||| IN
interact  ||| S:915 E:924 ||| NN
with  ||| S:924 E:929 ||| IN
those  ||| S:929 E:935 ||| DT
factors ||| S:935 E:942 ||| NNS
.  ||| S:942 E:944 ||| .
Although  ||| S:944 E:953 ||| IN
acute  ||| S:953 E:959 ||| JJ
hypothalamic-pituitary-adrenal  ||| S:959 E:990 ||| JJ
axis  ||| S:990 E:995 ||| JJ
responses  ||| S:995 E:1005 ||| NNS
to  ||| S:1005 E:1008 ||| TO
stress  ||| S:1008 E:1015 ||| VB
are  ||| S:1015 E:1019 ||| VBP
generally  ||| S:1019 E:1029 ||| RB
adaptive ||| S:1029 E:1037 ||| JJ
,  ||| S:1037 E:1039 ||| ,
excessive  ||| S:1039 E:1049 ||| JJ
responses  ||| S:1049 E:1059 ||| NNS
can  ||| S:1059 E:1063 ||| MD
lead  ||| S:1063 E:1068 ||| VB
to  ||| S:1068 E:1071 ||| TO
deleterious  ||| S:1071 E:1083 ||| VB
effects ||| S:1083 E:1090 ||| NNS
.  ||| S:1090 E:1092 ||| .
Early-life  ||| S:1092 E:1103 ||| JJ
stress  ||| S:1103 E:1110 ||| NN
alters  ||| S:1110 E:1117 ||| VBZ
hypothalamic-pituitary-adrenal  ||| S:1117 E:1148 ||| JJ
axis  ||| S:1148 E:1153 ||| JJ
function  ||| S:1153 E:1162 ||| NN
and  ||| S:1162 E:1166 ||| CC
behavior ||| S:1166 E:1174 ||| NN
,  ||| S:1174 E:1176 ||| ,
but  ||| S:1176 E:1180 ||| CC
the  ||| S:1180 E:1184 ||| DT
pattern  ||| S:1184 E:1192 ||| NN
of  ||| S:1192 E:1195 ||| IN
hypothalamic-pituitary-adrenal  ||| S:1195 E:1226 ||| JJ
dysfunction  ||| S:1226 E:1238 ||| NN
and  ||| S:1238 E:1242 ||| CC
psychological  ||| S:1242 E:1256 ||| JJ
outcome  ||| S:1256 E:1264 ||| NN
in  ||| S:1264 E:1267 ||| IN
adulthood  ||| S:1267 E:1277 ||| NNS
reflect  ||| S:1277 E:1285 ||| VBP
both  ||| S:1285 E:1290 ||| PDT
the  ||| S:1290 E:1294 ||| DT
characteristics  ||| S:1294 E:1310 ||| NN
of  ||| S:1310 E:1313 ||| IN
the  ||| S:1313 E:1317 ||| DT
stressor  ||| S:1317 E:1326 ||| NN
and  ||| S:1326 E:1330 ||| CC
other  ||| S:1330 E:1336 ||| JJ
modifying  ||| S:1336 E:1346 ||| JJ
factors ||| S:1346 E:1353 ||| NNS
.  ||| S:1353 E:1355 ||| .
Research  ||| S:1355 E:1364 ||| NN
to  ||| S:1364 E:1367 ||| TO
date  ||| S:1367 E:1372 ||| NN
has  ||| S:1372 E:1376 ||| VBZ
identified  ||| S:1376 E:1387 ||| VBN
multiple  ||| S:1387 E:1396 ||| JJ
determinants  ||| S:1396 E:1409 ||| NN
of  ||| S:1409 E:1412 ||| IN
the  ||| S:1412 E:1416 ||| DT
hypothalamic-pituitary-adrenal  ||| S:1416 E:1447 ||| JJ
axis  ||| S:1447 E:1452 ||| NNS
dysfunction  ||| S:1452 E:1464 ||| VBP
seen  ||| S:1464 E:1469 ||| VBN
in  ||| S:1469 E:1472 ||| IN
adults  ||| S:1472 E:1479 ||| NNS
with  ||| S:1479 E:1484 ||| IN
a  ||| S:1484 E:1486 ||| DT
history  ||| S:1486 E:1494 ||| NN
of  ||| S:1494 E:1497 ||| IN
childhood  ||| S:1497 E:1507 ||| NN
maltreatment  ||| S:1507 E:1520 ||| NNS
or  ||| S:1520 E:1523 ||| CC
other  ||| S:1523 E:1529 ||| JJ
early-life  ||| S:1529 E:1540 ||| JJ
stress ||| S:1540 E:1546 ||| NN
.  ||| S:1546 E:1548 ||| .
Further  ||| S:1548 E:1556 ||| JJ
work  ||| S:1556 E:1561 ||| NN
is  ||| S:1561 E:1564 ||| VBZ
needed  ||| S:1564 E:1571 ||| VBN
to  ||| S:1571 E:1574 ||| TO
establish  ||| S:1574 E:1584 ||| VB
whether  ||| S:1584 E:1592 ||| IN
hypothalamic-pituitary-adrenal  ||| S:1592 E:1623 ||| JJ
axis  ||| S:1623 E:1628 ||| JJ
abnormalities  ||| S:1628 E:1642 ||| NN
in  ||| S:1642 E:1645 ||| IN
this  ||| S:1645 E:1650 ||| DT
context  ||| S:1650 E:1658 ||| NN
can  ||| S:1658 E:1662 ||| MD
be  ||| S:1662 E:1665 ||| VB
used  ||| S:1665 E:1670 ||| VBN
to  ||| S:1670 E:1673 ||| TO
develop  ||| S:1673 E:1681 ||| VB
risk  ||| S:1681 E:1686 ||| NN
endophenotypes  ||| S:1686 E:1701 ||| NN
for  ||| S:1701 E:1705 ||| IN
psychiatric  ||| S:1705 E:1717 ||| JJ
and  ||| S:1717 E:1721 ||| CC
physical  ||| S:1721 E:1730 ||| JJ
illnesses ||| S:1730 E:1739 ||| NNS
.  ||| S:1739 E:1741 ||| .
